Letter: The FDA regarding the use of the Sargenti type formulations.
D006801:Humans; D012387:Root Canal Filling Materials; D012390:Root Canal Therapy / Q000379:methods*; D014481:United States; D014486:United States Food and Drug Administration
D012387:Root Canal Filling Materials